PD L1 News and Research

RSS
Glioma microenvironment emerges as key target for future therapies

Glioma microenvironment emerges as key target for future therapies

Red blood cells inspire next-generation therapeutic nanocarriers

Red blood cells inspire next-generation therapeutic nanocarriers

Engineered red blood cell vesicles improve gene therapy delivery

Engineered red blood cell vesicles improve gene therapy delivery

NIH funds research to explore the role of thymulin in inflammaging and cancer

NIH funds research to explore the role of thymulin in inflammaging and cancer

New strategy combines cancer immunotherapy and gene therapy in a single nanoparticle

New strategy combines cancer immunotherapy and gene therapy in a single nanoparticle

Phase 3 clinical trial enrolls first platinum-resistant ovarian cancer patient

Phase 3 clinical trial enrolls first platinum-resistant ovarian cancer patient

Engineered probiotic bacteria boost immune attack against pancreatic cancer

Engineered probiotic bacteria boost immune attack against pancreatic cancer

Thymulin curbs age-related inflammation and slows breast tumors in mice

Thymulin curbs age-related inflammation and slows breast tumors in mice

City of Hope launches trial to map how tumors change during immunotherapy resistance

City of Hope launches trial to map how tumors change during immunotherapy resistance

Thymus hormone identified as key player in reversing age-related inflammation

Thymus hormone identified as key player in reversing age-related inflammation

Six-gene signature predicts colorectal cancer recurrence after liver metastases

Six-gene signature predicts colorectal cancer recurrence after liver metastases

Feeder-free TIL expansion system makes advanced cancer immunotherapy safer

Feeder-free TIL expansion system makes advanced cancer immunotherapy safer

New breast cancer classification system predicts immunotherapy response success

New breast cancer classification system predicts immunotherapy response success

New AI model improves prediction of cancer immunotherapy success

New AI model improves prediction of cancer immunotherapy success

Reversing macrophage metabolism may improve cancer immunotherapy outcomes

Reversing macrophage metabolism may improve cancer immunotherapy outcomes

New AI framework outperforms conventional biomarkers in predicting cancer survival

New AI framework outperforms conventional biomarkers in predicting cancer survival

Copper-induced cell death stimulates antitumor immune cell responses

Copper-induced cell death stimulates antitumor immune cell responses

New study frames altered protein modifications as cancer drivers

New study frames altered protein modifications as cancer drivers

Roswell Park scientists present five key cancer studies at clinical meeting

Roswell Park scientists present five key cancer studies at clinical meeting

Researchers uncover immune mechanisms behind polycystic kidney disease progression

Researchers uncover immune mechanisms behind polycystic kidney disease progression

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.